13F reference period
Q3 2026
CUSIP: 004468500
13F reference period
Q3 2026
Institutions Reporting
89
Shares (Excl. Options)
Price
$8.09
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 89 institutions filings for Q3 2026.
Security key
004468500
13F reference period
Q3 2026
13F holders
89
13D/G owners
13
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 004468500:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TPG GP A, LLC | 13% | $40,440,170 | 13,755,160 | TPG GP A, LLC | 17 Apr 2025 | |||
| venBio Global Strategic Fund V, L.P. | 10% | $31,567,712 | 10,737,317 | venBio Global Strategic Fund V, L.P. | 15 Apr 2026 | |||
| Paradigm Biocapital Advisors LP | 9.2% | $29,116,913 | 9,903,712 | Paradigm BioCapital Advisors LP | 17 Apr 2026 | |||
| Logos Global Management LP | 8.6% | -14% | $67,914,448 | -$5,854,632 | 9,702,064 | -7.9% | Logos Global Management LP | 30 Sep 2026 |
| FRANKLIN RESOURCES INC | 8.3% | +35% | $57,979,491 | +$16,388,276 | 8,878,942 | +39% | Franklin Resources, Inc. | 30 Jun 2026 |
| Frazier Life Sciences Public Fund, L.P. | 6.5% | $19,479,817 | 6,625,788 | Frazier Life Sciences Public Fund, L.P. | 17 Apr 2026 | |||
| Venrock Healthcare Capital Partners III, L.P. | 5.2% | 0% | $39,559,840 | 5,502,064 | 0% | Venrock Healthcare Capital Partners III, L.P. | 30 Sep 2026 | |
| Janus Henderson Group Ltd. | 5.4% | $33,562,590 | 5,502,064 | JANUS HENDERSON GROUP Ltd. | 30 Jun 2026 | |||
| Vivo Opportunity Fund Holdings, L.P. | 5% | $29,287,133 | 5,305,640 | Vivo Opportunity, LLC | 06 Jul 2026 | |||
| BlackRock, Inc. | 5.1% | +450% | $34,422,183 | +$32,367,199 | 5,271,391 | +1575% | BlackRock, Inc. | 30 Jun 2026 |
| Alyeska Investment Group, L.P. | 3.2% | -40% | $23,792,105 | +$2,346,334 | 3,309,055 | +11% | Alyeska Investment Group, L.P. | 30 Sep 2026 |
| Contrarian Alpha, LP | 4.9% | $7,964,388 | 2,528,377 | Parker Quillen | 30 Sep 2025 | |||
| VANGUARD GROUP INC | 5% | $4,086,493 | 1,717,014 | The Vanguard Group | 31 Mar 2025 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7.2% | 7,614,836 | 1.5% | $61,604,023 | |
| TPG GP A, LLC | 6.5% | 6,877,580 | 1.4% | $55,639,622 | |
| Logos Global Management LP | 5.6% | 5,951,032 | 2.8% | $48,143,849 | |
| venBio Partners LLC | 5.6% | 5,914,720 | 9.6% | $47,850,085 | |
| Venrock Adviser, LLC | 5.2% | 5,502,064 | 2.2% | $44,511,698 | |
| Paradigm Biocapital Advisors LP | 4.7% | 4,951,856 | 0.8% | $40,060,515 | |
| Propel Bio Management, LLC | 3.7% | 3,864,148 | 17% | $31,260,957 | |
| MARSHALL WACE, LLP | 3.6% | 3,770,313 | 0.03% | $30,501,830 | |
| STATE STREET CORP | 3.5% | 3,718,240 | 0% | $30,080,562 | |
| EVENTIDE ASSET MANAGEMENT, LLC | 3.4% | 3,571,721 | 0.4% | $28,895,223 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.3% | 3,480,234 | 0% | $28,155,093 | |
| Vivo Capital, LLC | 2.6% | 2,751,032 | 2.4% | $22,255,849 | |
| Janus Henderson Group Ltd. | 2.6% | 2,751,032 | 0.01% | $22,255,849 | |
| ORBIMED ADVISORS LLC | 2.2% | 2,344,200 | 0.35% | $18,964,578 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2% | 2,156,709 | 0% | $17,451,896 | |
| Boxer Capital Management, LLC | 2% | 2,150,000 | 1.5% | $17,393,500 | |
| WELLINGTON MANAGEMENT GROUP LLP | 1.6% | 1,648,859 | 0% | $13,339,269 | |
| Alyeska Investment Group, L.P. | 0.92% | 975,722 | 0.02% | $7,893,591 | |
| LPL Financial LLC | 0.92% | 973,585 | 0% | $7,876,303 | |
| Simplify Asset Management Inc. | 0.88% | 932,105 | 0.13% | $7,540,729 | |
| Spruce Street Capital LP | 0.7% | 736,637 | 0.95% | $5,959,393 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.69% | 735,325 | 0% | $5,948,779 | |
| VANGUARD FIDUCIARY TRUST CO | 0.59% | 620,907 | 0% | $5,023,138 | |
| RAYMOND JAMES FINANCIAL INC | 0.55% | 583,491 | 0% | $4,720,443 | |
| MERCER GLOBAL ADVISORS INC /ADV | 0.52% | 550,551 | 0.01% | $4,453,961 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 83,191,490 | $669,395,240 | +$91,607,275 | $8.09 | 89 |
| 2026 Q2 | 82,509,056 | $538,747,341 | +$386,629,895 | $6.53 | 111 |
| 2026 Q1 | 21,523,954 | $63,555,449 | -$6,062,639 | $2.94 | 79 |
| 2025 Q4 | 23,239,545 | $115,291,318 | +$36,552,641 | $4.97 | 77 |
| 2025 Q3 | 15,541,415 | $48,917,159 | -$26,338,868 | $3.15 | 65 |
| 2025 Q2 | 26,238,674 | $59,299,106 | +$26,395,211 | $2.26 | 64 |
| 2025 Q1 | 14,388,656 | $38,412,610 | -$6,420,566 | $2.67 | 72 |
| 2024 Q4 | 16,340,748 | $57,510,675 | -$2,280,524 | $3.52 | 70 |
| 2024 Q3 | 16,929,998 | $81,217,159 | +$2,394,591 | $4.74 | 64 |
| 2024 Q2 | 12,513,128 | $58,811,518 | +$9,414,756 | $4.70 | 54 |
| 2024 Q1 | 10,495,260 | $47,701,835 | +$35,368,247 | $4.54 | 39 |
| 2023 Q4 | 2,727,493 | $11,236,940 | -$1,729,113 | $4.12 | 29 |
| 2023 Q3 | 3,117,219 | $13,403,691 | -$2,279,792 | $4.30 | 35 |
| 2023 Q2 | 3,562,232 | $18,487,663 | +$5,645,131 | $5.19 | 38 |
| 2023 Q1 | 2,470,554 | $16,600,668 | +$3,392,110 | $6.80 | 31 |
| 2022 Q4 | 1,999,698 | $4,902,826 | -$458,841 | $2.45 | 27 |
| 2022 Q3 | 2,121,733 | $7,001,230 | +$176,107 | $3.30 | 28 |
| 2022 Q2 | 2,043,015 | $9,968,000 | -$109,417 | $4.88 | 31 |
| 2022 Q1 | 1,932,821 | $14,633,000 | -$2,149 | $7.57 | 33 |
| 2021 Q4 | 1,918,795 | $14,925,000 | +$535,636 | $7.78 | 26 |
| 2021 Q3 | 1,782,658 | $15,149,000 | -$1,185,059 | $8.50 | 30 |
| 2021 Q2 | 1,948,272 | $17,498,000 | +$7,592,533 | $8.98 | 28 |
| 2021 Q1 | 1,007,113 | $11,662,000 | +$6,322,912 | $11.58 | 16 |
| 2020 Q4 | 493,003 | $3,994,000 | +$307,274 | $8.10 | 14 |
| 2020 Q3 | 452,590 | $3,789,000 | +$3,789,000 | $8.37 | 12 |